Skip To Main Content
Zuoying Dist on Muck Rack

Zuoying Dist

As seen in: Oxford Academic, MarketScreener
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zuoying

Contact Zuoying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Exploring the Ca2+ signaling and cytotoxicity induced by the alantolactone in breast cancer cells and its potential implications in treatment using the Ca2+ chelating agent BAPTA-AM

|
By Zuoying Dist, Jishan Rd, Zhushan Township, Weixin Rd
| Oxford Academic Verified
Alantolactone, a bioactive sesquiterpene lactone derived from the roots of Inula helenium (elecampane), has garnered attention in biomedical and pharmacological research for its diverse therapeutic properties, including anticancer, anti-inflammatory, antimicrobial, and antioxidant activities. Despite its well-documented bioactivity, the effects of alantolactone on calcium ion (Ca2+) signaling and the underlying mechanisms in human breast cancer cells remain poorly understood.
Open in Who Shared Issue with article?

Percutaneous Endovascular Creation of a Neo-arteriovenous Fistula in Dysfunctional Hemodialysis Fistulas - CardioVascular and Interventional Radiology

|
By Zuoying Dist, Taiwan ROC
| link.springer.com
Abstract Arteriovenous fistulas (AVF) is the preferred type of hemodialysis access, but when an arteriovenous anastomosis (AVA) calcifies, surgical revision of the AVF may be required. We report a technique to create percutaneous artery-to-vein intervascular neo-fistulas for re-anastomosis of AVA and evaluate its safety and efficacy.
Open in Who Shared Issue with article?

Power Wind Health Industry Incorporated : Announcement of the Company's BoD resolved to convene the 2022 Annual Shareholders' Meeting (Additional matters) | MarketScreener

|
By Zuoying Dist, Kaohsiung City, Chongde Rd, Parent company-only
| MarketScreener
Close Provided by: Power Wind Health Industry Incorporated SEQ_NO 3 Date of announcement 2022/04/18 Time of announcement 18:15:10 Subject Announcement of the Company's BoD resolved to convene the 2022 Annual Shareholders' Meeting (Additional matters) Date of events 2022/04/18 To which item it meets paragraph 17 Statement 1.Date of the board of directors' resolution:2022/04/18 2.Shareholders meeting date:2022/06/01 3.Shareholders meeting location: No. 801, Chongde Rd., Zuoying Dist., Kaohsiung...
Open in Who Shared Issue with article?
See all 4 articles